Back to FRANKLIN TEMPLETON INC FRANKLIN TEMPLETON INC

ABBVABBV
Showing 8 of 28 quarters

Position history for FRANKLIN TEMPLETON INCFRANKLIN TEMPLETON INC's holdings in ABBVIE INC

Yes. Franklin Templeton holds 19,925,232 shares of ABBV (AbbVie), worth $5B, as of its Q2 2026 13F filing. It increased the position by 5,373,163 shares (+36.9%) from Q1 2026. Franklin Templeton has held ABBV in every 13F on record since Q3 2019, 28 quarterly filings. ABBV is 1.1% of Franklin Templeton's reported 13F portfolio.

Current Value

$5B

Current Shares

19.9M

Total Value Change

+$2.3B

Total Shares Change

+6.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
19.9M
+36.9%
$5B1.1%$248.34
66
2026-Q1
Decreased
14.6M
-2.2%
$3.2B0.8%$212.87
0
2025-Q4
Increased
14.9M
+2.3%
$3.4B0.8%$221.85
46
2025-Q3
Decreased
14.6M
-3.7%
$3.4B0.8%$223.20
0
2025-Q2
Decreased
15.1M
-14.5%
$2.8B0.7%$177.40
0
2025-Q1
Increased
17.7M
+2.5%
$3.7B1.1%$198.41
51
2024-Q4
Increased
17.2M
+24.3%
$3.1B0.9%$166.71
55
2024-Q3
Decreased
13.9M
-13.0%
$2.7B0.8%$183.80
0

Other major holders of ABBV: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used